Reminder: Invitation to Roche’s virtual ESG event: Access to Healthcare Montag, 09. Mai 2022 - 10:08

We are pleased to invite investors and analysts to participate in our virtual event on
Monday, 16 May 2022, presenting Roche's access to healthcare strategy highlighting initiatives from both the Diagnostics and Pharmaceuticals divisions.

15:00 – 16:30 CEST / 14:00 - 15:30 BST

09:00 – 10:30 am EDT / 6:00 – 7:30 am PDT

The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 14:00 CEST on the day of the event. > click here

Agenda
Welcome
Bruno Eschli, Head of Investor Relations

Roche Sustainability Strategy
Pascale Schmidt, Chief Compliance and Sustainability Officer

How Roche Diagnostics enables access to healthcare
Thomas Schinecker, CEO Roche Diagnostics

Driving Access to Diagnostics across the Globe
Stefan Seliger, Head Global Access & Policy, Diagnostics Division

Driving Access to Medicine across the Globe
Michael Oberreiter, Head Global Access, Pharmaceuticals Division

Q&A

Access to virtual event (pre-registration required)
Please pre-register for our webinar here*.

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.

A replay of the webcast will be available via > ir.roche.com

*privacy notice

Best regards,

Bruno Eschli
Head of Investor Relations

Roche Investor Relations

Dr. Bruno Eschli

Phone: +41 61 68-75284

e-mail: bruno.eschli@roche.com

Dr. Sabine Borngräber

Phone: +41 61 68-88027

e-mail: sabine.borngraeber@roche.com

Dr. Birgit Masjost

Phone: +41 61 68-84814

e-mail: birgit.masjost@roche.com

Dr. Gerard Tobin

Phone: +41 61 68-72942

e-mail: gerard.tobin@roche.com

Investor Relations North America

Loren Kalm

Phone: +1 650 225 3217

e-mail: kalm.loren@gene.com